<DOC>
	<DOCNO>NCT02603770</DOCNO>
	<brief_summary>The objective study compare laboratory test profile botanic drug XueZhiKang ( XZK ) 300 mg capsule versus market drug Lovastatin 20 mg tablet healthy male volunteer 18 50 year age .</brief_summary>
	<brief_title>Compare Pharmacokinetic ( PK ) Profiles XZK v Lovastatin Healthy Male Volunteers</brief_title>
	<detailed_description>Twenty ( 20 ) healthy male subject enrol assign either XZK group Lovastatin group 1:1 ratio one site USA .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>Capable give informed consent comply study procedure ; Male subject age 18 50 year , inclusive ; Considered healthy PI , base detailed medical history , physical examination , clinical laboratory test , 12lead ECG vital sign ; Nonsmoker , define smoke used form tobacco 6 month screen ; Body Mass Index ( BMI ) 19 32 kg/m2 inclusive body weight less 50 mg ; Willing able adhere study restriction confine clinical research center . Clinically significant past history gastrointestinal , cardiovascular , musculoskeletal , endocrine , hematologic , psychiatric , renal , hepatic , bronchopulmonary , neurologic , immunologic , lipid metabolism disorder , drug hypersensitivity ; History presence malignancy adequately treat basal cell skin cancer ; Clinically relevant illness within one month prior screen visit screen visit may interfere conduct study ; Positive blood screen human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAG ) hepatitis C antibody ; A history seizure . However , history febrile seizure allow ; A hospital admission major surgery within 30 day prior screen ; Participation investigational drug trial within 30 day last dosing trial screen ; A history prescription drug abuse , illicit drug use within 6 month prior screen ; A history alcohol abuse accord medical history within 6 month prior screen ; A positive screen alcohol , drug abuse ; Tobacco use within 6 month prior screen base subject report ; Subjects hypersensitivity lipidlowering agent ; Subjects participate previous clinical study XZK ; An unwillingness inability comply food beverage restriction study participation ; Donation blood collection 1 unit ( approximately 450 ml ) blood ( blood product ) acute loss blood 90 day prior screen ; Use prescription overthecounter ( OTC ) medication , herbal ( include St. John 's Wort , herbal tea , garlic extract ) within 14 day prior dose ( Note : Use acetaminophen &lt; 3g/day permit 24 hour prior dose ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>